Inventor · disambiguated record
Joseph Schoepfer
Also filed as: SCHOEPFER JOSEPH · SCHOEPFER JOSEPH G
13 granted patents·21 pending applications·189 citations·filing 2004–2023
90Inventor score
Top patents by PatentIndex Score
34 records- 0195US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 0288US11878973B2Bicyclic compounds and their usesNOVARTIS AG·Filed 2022·Granted Jan 23, 2024·4 cites·37 claims
- 0386US8829195B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1DODD STEPHANIE KAY·Filed 2013·Granted Sep 9, 2014·16 cites·16 claims
- 0485US9340537B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted May 17, 2016·4 cites·3 claims
- 0585US9278981B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Mar 8, 2016·6 cites·18 claims
- 0684US8389526B23-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivativesFURET PASCAL·Filed 2010·Granted Mar 5, 2013·4 cites·9 claims
- 0782US7189729B2Methods and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Mar 13, 2007·18 cites·7 claims
- 0872US8822468B23-Methyl-imidazo[1,2-b]pyridazine derivativesFURET PASCAL·Filed 2009·Granted Sep 2, 2014·2 cites·3 claims
- 0968US7795288B2Thiazole and pyrazole derivatives as Flt-3 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Sep 14, 2010·3 cites·6 claims
- 1065US2024360118A1Bicyclic Compounds and their UsesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1159US2024197715A1Pharmaceutical combinations and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1259US2024245694A1Tricyclic Compounds and their UsesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1358US2010210650A1Isoxazole compound for the treatment of cancerNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1458US2018134695A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1FURET PASCAL·Filed 2018·Application pending·0 cites
- 1557US9896444B2Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Feb 20, 2018·0 cites·5 claims
- 1655US2009099167A1Organic compoundsNOVARTIS INST FOR BIOMEDICAL R·Filed 2008·Application pending·0 cites
- 1754US8217045B2Organic compoundsMANLEY PAUL W·Filed 2008·Granted Jul 10, 2012·0 cites·9 claims
- 1852US2013012704A1Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2012·Application pending·0 cites
- 1952US2013012476A1Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2012·Application pending·0 cites
- 2051US9458112B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2016·Granted Oct 4, 2016·0 cites·8 claims
- 2151US2014288075A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2014·Application pending·0 cites
- 2250US9315489B2Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1FURET PASCAL·Filed 2013·Granted Apr 19, 2016·0 cites·20 claims
- 2350US2006211747A1Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this methodFURET PASCAL·Filed 2005·Application pending·0 cites
- 2449US2010311729A1Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitorsCAPRARO HANS-GEORG·Filed 2008·Application pending·0 cites
- 2548US2014343086A1Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1DODD STEPHANIE KAY·Filed 2014·Application pending·0 cites
- 2647US2012214813A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2012·Application pending·0 cites
- 2747US2005222171A1Organic compoundsBOLD GUIDO·Filed 2005·Application pending·0 cites
- 2846US2016220576A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2016·Application pending·0 cites
- 2946US2012083496A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2011·Application pending·0 cites
- 3044US2016045513A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2015·Application pending·0 cites
- 3140US2008311038A1Radicicol Derivatives Useful for Position Emission TomographyAUBERSON YVES·Filed 2007·Application pending·0 cites
- 3239US2009039811A1Inhibitors of HSP90CHENE PATRICK·Filed 2005·Application pending·0 cites
- 3339US2009069341A1Inhibitors of hsp90CHENE PATRICK·Filed 2005·Application pending·0 cites
- 3438US2007249639A1Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine DerivativesBAENTELI ROLF·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →